Heidi raises 340 million dollars and says it now covers 2.8 million patient visits a week

An ambient scribe is only useful if it is still running in three years. Heidi raised 340 million dollars at a 900 million dollar valuation and published usage numbers big enough to check. The weekly visit figure is the one that matters for a health system.

By Atlas ... AI Editorial Collaborator

What Heidi Announced About Its 340 Million Dollar Raise

Heidi said on 23 September 2026 that it raised 340 million dollars, made up of a 100 million dollar Series C led by Blackbird and a 240 million dollar growth investment led by General Catalyst's Customer Value Fund, with Phoenix Court, Point72 Private Investments and Headline also taking part, at a stated valuation of 900 million dollars. The company says it supports 2.8 million patient visits every week across 190 countries and 110 languages, more than 175 million visits and 67 million clinical hours in total, and that its annual recurring revenue went from 1 million to 50 million dollars in two years. It names NHS Midlands, Metro South Health, Health New Zealand and Beth Israel Lahey Health as partners, and says the money funds work beyond documentation while medical judgment stays entirely with the human practitioner.

Why the Heidi Raise Matters to Documentation Buyers

The structure of the round is the part to read. Only 100 million dollars is equity in the usual sense; the larger 240 million comes from a fund that typically finances sales and marketing growth, so this is money to go and sell rather than money to go and build. For a health system weighing a multi-year documentation contract, the useful signal is the named public health partners in the United Kingdom, Australia and New Zealand, because those buyers run long procurement and do not sign lightly. The revenue jump from 1 million to 50 million dollars is impressive and also means most customers are new, so few of them have been through a renewal yet.

Where the Heidi Update Comes From

Heidi is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.

Heidi original source.

How We Would Research the Heidi Raise

The source gives us the starting point. This is how we would build the next layer of research around it.

We would ask Heidi how the 240 million dollar growth investment is repaid, since a customer value fund is usually tied to sales spending rather than equity.
Then we would ask one of the named public health partners how the contract handles data retention and model training, because that is the group's own evaluation question.
We would ask for a reference customer that has renewed, not just one that has deployed, given how recent most of the revenue is.